Kula Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kula Investments's BMY Position: Q1 2023 in Review
Kula Investments reduced its Bristol-Myers Squibb (BMY) stake by 41% in Q1 2023, selling an estimated $716K and leaving 14,547 shares worth $1.01M. The position accounts for 0.25% of the portfolio, ranked #123.
Kula Investments first reported a position in BMY in Q4 2022 and has held it in 2 quarters since. The position peaked at $1.78M in Q4 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.
- Kula Investments held 14,547 shares of Bristol-Myers Squibb worth $1.01M as of Q1 2023.
- Kula Investments sold 10,155 Bristol-Myers Squibb shares in Q1 2023, an estimated $716K.
- Bristol-Myers Squibb made up 0.25% of Kula Investments's portfolio in Q1 2023, its #123 holding.
- Kula Investments first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 2 quarters since.
- Kula Investments's Bristol-Myers Squibb position peaked at $1.78M in Q4 2022.
- 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.
Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.